ArticleJournal of the American Heart Association2021
Impact of Morbid Obesity and Obesity Phenotype on Outcomes After Transcatheter Aortic Valve Replacement.
Abstract readMulticenter StudyVideo-Audio Media
In one paragraph
Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- CT-derived adipose tissue characteristics and TAVI all-cause mortality and complications: a systematic review.European journal of medical research · 2025Pooled it
- Deep Learning-Derived Body Composition Analysis Predicts Long-Term Mortality After Transcatheter Aortic Valve Replacement.Mayo Clinic proceedings. Digital health · 2026Article
- Assessing the prognostic impact of body composition phenotypes on surgical outcomes in patients with acute type A aortic dissection.Journal of thoracic disease · 2026Article
- BMI Is Unreliable When Studying the Obesity Paradox in TAVR.JACC. Asia · 2026Article
- The 'obesity paradox' in patients undergoing transcatheter aortic valve implantation. A specialized narrative review.American heart journal plus : cardiology research and practice · 2026Review
- Reply: BMI is Unreliable When Studying the Obesity Paradox in TAVR.JACC. Asia · 2026Article
- Epicardial adipose tissue as an independent predictor of long-term outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.Clinical research in cardiology : official journal of the German Cardiac Society · 2025Article
- Body composition of metabolically unhealthy normal-weight patients with aortic stenosis: a prospective cohort study.BMC cardiovascular disorders · 2024Article
- Minimally Invasive Aortic Valve Replacement for High-Risk Populations: Transaxillary Access Enhances Survival in Patients with Obesity.Journal of clinical medicine · 2024Article
- Effect of Elevated Body Mass Index on Outcomes of Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis.Anatolian journal of cardiology · 2024Article
- Obesity Paradox in Transcatheter Aortic Valve Replacement.Current cardiology reports · 2024Review
- Obesity and Transcatheter Aortic Valve Replacement.Journal of cardiovascular development and disease · 2024Review
- Article
- Article
- A Meta-Analysis on the Impact of High BMI in Patients Undergoing Transcatheter Aortic Valve Replacement.Journal of cardiovascular development and disease · 2022Review
- Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022Article
- Impact of Morbid Obesity and Obesity Phenotype on Outcomes After Transcatheter Aortic Valve Replacement.Journal of the American Heart Association · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Angela McInerneyCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Gabriela Tirado-ConteCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Josep Rodes-CabauQuebec Heart and Lung InstituteLaval University Quebec City Quebec Canada.
Francisco Campelo-ParadaCardiology Department Rangueil University Hospital Toulouse France.
Jose D Tafur SotoThe Ochsner Clinical School Ochsner Medical Center New Orleans LA.
Marco BarbantiFerrarotto Hospital University of Catania Catania Italy.
Erika Muñoz-GarciaCentro de Investigación Biomédica en Red Enfermedades Cardiovasculares Cardiology Department Hospital Universitario Virgen de la Victoria Málaga Spain.
Mobeena ArifDivision of Cardiology St. Michael's HospitalToronto University Toronto Ontario Canada.
Diego LopezHospital Clínico Universitario de SantiagoCIBERCV Santiago Spain.
Stefan ToggweilerHeart Center Lucerne Luzerner Kantonsspital Lucerne Switzerland.
Gabriela VeigaHospital Universitario Marques de Valdecilla IDIVAL Santander Spain.
Anna PylkoDepartment of Interventional Cardiology and Angiology National Institute of Cardiology Warsaw Poland.
Teresa SevillaCIBERCVInstituto de Ciencias del CorazónHospital Clínico Universitario de Valladolid Valladolid Spain.
Miriam CompagnoneCardiology Unit Cardio-Thoracic-Vascular Department University Hospital of BolognaPoliclinico S, Orsola-Malpighi Bologna Italy.
Ander RegueiroCardiology Department Cardiovascular Institute, Hospital ClínicUniversidad de BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer Barcelona Spain.
Viçent SerraHospital General Universitari Vall d'Hebron Barcelona Spain.
Manuel CarneroCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Juan F OteoDepartment of Cardiology Hospital Universitario Puerta de Hierro Majadahonda Spain.
Fernando RiveroCardiology Department Hospital Universitario de la PrincesaInstituto de Investigación Sanitaria Princesa (IIS-IP)Universidad Autónoma de Madrid, CIBER-CV Madrid Spain.
Henrique Barbosa RibeiroHeart Institute (Instituto de Coraçāo) Sao Paulo Brazil.
Leonardo GuimaraesQuebec Heart and Lung InstituteLaval University Quebec City Quebec Canada.
Anthony MattaCardiology Department Rangueil University Hospital Toulouse France.
Natalia Giraldo EchavarriaThe Ochsner Clinical School Ochsner Medical Center New Orleans LA.
Roberto ValvoFerrarotto Hospital University of Catania Catania Italy.
Federico MoccettiHeart Center Lucerne Luzerner Kantonsspital Lucerne Switzerland.
Antonio J Muñoz-GarciaCentro de Investigación Biomédica en Red Enfermedades Cardiovasculares Cardiology Department Hospital Universitario Virgen de la Victoria Málaga Spain.
Javier Lopez-PaisHospital Clínico Universitario de SantiagoCIBERCV Santiago Spain.
Bruno Garcia Del BlancoHospital General Universitari Vall d'Hebron Barcelona Spain.
Diego Carter Campanha BorgesHeart Institute (Instituto de Coraçāo) Sao Paulo Brazil.
Eric DumontQuebec Heart and Lung InstituteLaval University Quebec City Quebec Canada.
Nieves GonzaloCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Enrico CriscioneFerrarotto Hospital University of Catania Catania Italy.
Maciej DabrowskiDepartment of Interventional Cardiology and Angiology National Institute of Cardiology Warsaw Poland.
Fernando AlfonsoCardiology Department Hospital Universitario de la PrincesaInstituto de Investigación Sanitaria Princesa (IIS-IP)Universidad Autónoma de Madrid, CIBER-CV Madrid Spain.
Jose M de la Torre HernándezHospital Universitario Marques de Valdecilla IDIVAL Santander Spain.
Asim N CheemaDivision of Cardiology St. Michael's HospitalToronto University Toronto Ontario Canada.
Ignacio J Amat-SantosCIBERCVInstituto de Ciencias del CorazónHospital Clínico Universitario de Valladolid Valladolid Spain.
Francesco SaiaCardiology Unit Cardio-Thoracic-Vascular Department University Hospital of BolognaPoliclinico S, Orsola-Malpighi Bologna Italy.
Javier EscanedCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Luis Nombela-FrancoCardiovascular InstituteHospital Clínico San CarlosInstituto de Investigación Sanitaria San Carlos Madrid Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background There is a paucity of outcome data on patients who are morbidly obese (MO) undergoing transcatheter aortic valve replacement. We aimed to determine their periprocedural and midterm outcomes and investigate the impact of obesity phenotype. Methods and Results Consecutive patients who are MO (body mass index, ≥40 kg/m
Indexed as
Transcatheter Aortic Valve ReplacementAdiposityAgedAged, 80 and overAortic Valve StenosisBody Mass IndexEuropeFemaleHumansIntra-Abdominal FatMaleObesity, MorbidPhenotypePostoperative ComplicationsRetrospective StudiesRisk Assessmentepicardial adipose tissuemorbid obesitysubcutaneous adipose tissuetranscatheter aortic valve replacementvisceral adipose tissue
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.